只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-29 2026-07-31 | SON SONOCO PRODUCTS CO | Florence John M Officer · Gnl Council, Secy, VP | 卖出（S） | 261 | US$58.56 | US$15,284.16 | 15,795 | SEC |
| 2026-07-28 2026-07-28 | UAL United Airlines Holdings, Inc. | Nocella Andrew P Officer · EVP & Chief Commercial Officer | 卖出（S） | 4,200 | US$120.48 | US$506,016.00 | 222,955 | SEC |
| 2026-07-17 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 3,656 | US$37.90 | US$138,562.40 | 298,901 | SEC |
| 2026-07-16 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 9,163 | US$36.46 | US$334,082.98 | 308,441 | SEC |
| 2026-07-16 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 5,865 | US$37.26 | US$218,529.90 | 302,576 | SEC |
| 2026-07-16 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 19 | US$37.96 | US$721.24 | 302,557 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 7,155 | US$36.16 | US$258,724.80 | 338,904 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 7,845 | US$37.04 | US$290,578.80 | 331,059 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 4,465 | US$36.00 | US$160,740.00 | 326,594 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 8,972 | US$36.99 | US$331,874.28 | 317,622 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 18 | US$37.54 | US$675.72 | 317,604 | SEC |
| 2026-07-01 2026-07-06 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 23,000 | US$123.59 | US$284.26万 | 58,117 | SEC |
| 2026-06-30 2026-07-01 | NCRA NOCERA, INC. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 199,781 | US$0.10 | US$20,177.88 | 1,347,050 | SEC |
| 2026-06-29 2026-07-01 | NCRA NOCERA, INC. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 117,565 | US$0.10 | US$12,109.20 | 1,546,831 | SEC |
| 2026-06-29 2026-07-01 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 5,500 | US$123.51 | US$679,305.00 | 58,117 | SEC |
| 2026-06-29 2026-06-29 | NONE First Trinity Financial CORP | Begnoche Alvin Joseph Officer · Vice President of Marketing | 买入（P） | 3,854 | US$3.66 | US$14,105.64 | 14,118 | SEC |
| 2026-06-26 2026-06-29 | NCRA NOCERA, INC. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 95,466 | US$0.10 | US$9,546.60 | 1,664,396 | SEC |
| 2026-06-25 2026-06-29 | NCRA NOCERA, INC. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 137,430 | US$0.09 | US$12,368.70 | 1,759,862 | SEC |
| 2026-06-24 2026-06-25 | NCRA NOCERA, INC. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 80,661 | US$0.10 | US$8,066.10 | 1,622,432 | SEC |
| 2026-06-23 2026-06-25 | NCRA NOCERA, INC. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 12,188 | US$0.11 | US$1,340.68 | 1,703,093 | SEC |
| 2026-06-10 2026-06-10 | COP CONOCOPHILLIPS | Mulligan Sharmila Director | 卖出（S） | 1,974 | US$119.00 | US$234,906.00 | 0 | SEC |
| 2026-06-09 2026-06-11 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 20,000 | US$122.81 | US$245.62万 | 58,117 | SEC |
| 2026-05-28 2026-06-01 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 1,300 | US$106.26 | US$138,138.00 | 62,317 | SEC |
| 2026-05-28 2026-06-01 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 1,422 | US$107.33 | US$152,623.26 | 60,895 | SEC |
| 2026-05-28 2026-06-01 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 1,178 | US$108.01 | US$127,235.78 | 59,717 | SEC |
| 2026-05-28 2026-06-01 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 1,500 | US$109.30 | US$163,950.00 | 58,217 | SEC |
| 2026-05-28 2026-06-01 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 100 | US$109.76 | US$10,976.00 | 58,117 | SEC |
| 2026-05-07 2026-05-11 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 4,321 | US$28.52 | US$123,234.92 | 346,176 | SEC |
| 2026-05-07 2026-05-11 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 117 | US$29.10 | US$3,404.70 | 346,059 | SEC |
| 2026-05-06 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 8,152 | US$28.04 | US$228,582.08 | 366,397 | SEC |
| 2026-05-06 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 15,900 | US$29.13 | US$463,167.00 | 350,497 | SEC |
| 2026-05-05 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 9,645 | US$28.12 | US$271,217.40 | 375,480 | SEC |
| 2026-05-05 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 931 | US$29.00 | US$26,999.00 | 374,549 | SEC |
| 2026-05-04 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 9,180 | US$27.50 | US$252,450.00 | 391,597 | SEC |
| 2026-05-04 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 5,460 | US$28.37 | US$154,900.20 | 386,137 | SEC |
| 2026-05-04 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 312 | US$29.56 | US$9,222.72 | 385,825 | SEC |
| 2026-05-04 2026-05-06 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 700 | US$30.08 | US$21,056.00 | 385,125 | SEC |
| 2026-05-04 2026-05-05 | NOC NORTHROP GRUMMAN CORP /DE/ | WELSH MARK A III Director | 卖出（S） | 1 | US$566.60 | US$566.60 | 4,215 | SEC |
| 2026-05-04 2026-05-05 | NOC NORTHROP GRUMMAN CORP /DE/ | WELSH MARK A III Director | 卖出（S） | 5 | US$568.75 | US$2,843.75 | 4,210 | SEC |
| 2026-05-04 2026-05-05 | NOC NORTHROP GRUMMAN CORP /DE/ | WELSH MARK A III Director | 卖出（S） | 9 | US$569.49 | US$5,125.41 | 4,201 | SEC |
| 2026-05-04 2026-05-05 | NOC NORTHROP GRUMMAN CORP /DE/ | WELSH MARK A III Director | 卖出（S） | 43 | US$570.47 | US$24,530.21 | 4,158 | SEC |
| 2026-05-04 2026-05-05 | NOC NORTHROP GRUMMAN CORP /DE/ | WELSH MARK A III Director | 卖出（S） | 3 | US$571.74 | US$1,715.22 | 4,155 | SEC |
| 2026-05-04 2026-05-05 | NOC NORTHROP GRUMMAN CORP /DE/ | WELSH MARK A III Director | 卖出（S） | 6 | US$572.72 | US$3,436.32 | 4,149 | SEC |
| 2026-05-04 2026-05-05 | NOC NORTHROP GRUMMAN CORP /DE/ | WELSH MARK A III Director | 卖出（S） | 14 | US$573.51 | US$8,029.14 | 4,135 | SEC |
| 2026-05-04 2026-05-05 | NOC NORTHROP GRUMMAN CORP /DE/ | WELSH MARK A III Director | 卖出（S） | 2 | US$574.51 | US$1,149.02 | 4,133 | SEC |
| 2026-05-04 2026-05-05 | NOC NORTHROP GRUMMAN CORP /DE/ | WELSH MARK A III Director | 卖出（S） | 4 | US$575.59 | US$2,302.36 | 4,129 | SEC |
| 2026-05-04 2026-05-05 | NOC NORTHROP GRUMMAN CORP /DE/ | WELSH MARK A III Director | 卖出（S） | 7 | US$576.38 | US$4,034.66 | 4,122 | SEC |
| 2026-05-04 2026-05-05 | NOC NORTHROP GRUMMAN CORP /DE/ | WELSH MARK A III Director | 卖出（S） | 1 | US$577.05 | US$577.05 | 4,121 | SEC |
| 2026-05-01 2026-05-05 | UAL United Airlines Holdings, Inc. | Nocella Andrew P Officer · EVP & Chief Commercial Officer | 卖出（S） | 7,000 | US$90.19 | US$631,330.00 | 215,345 | SEC |
| 2026-04-29 2026-05-01 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 300 | US$101.17 | US$30,351.00 | 58,117 | SEC |
| 2026-04-29 2026-05-01 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 700 | US$100.14 | US$70,098.00 | 58,417 | SEC |
| 2026-04-29 2026-05-01 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 4,500 | US$99.35 | US$447,075.00 | 59,117 | SEC |
| 2026-04-29 2026-04-30 | IBATF INTERNATIONAL BATTERY METALS LTD. | WARNOCK JACOB AARON Director,TenPercentOwner | 买入（P） | 34,315,465 | US$0.08 | US$274.52万 | 143,100,443 | SEC |
| 2026-04-27 2026-04-29 | SON SONOCO PRODUCTS CO | Harrell James A. III Officer · Pres. Global Ind. Paper Pkg. | 买入（P） | 6,753.31 | US$50.37 | US$340,164.22 | 10,069.62 | SEC |
| 2026-04-24 2026-04-24 | SON SONOCO PRODUCTS CO | Joachimczyk Paul Officer · CFO | 买入（P） | 8,058 | US$49.64 | US$399,999.12 | 28,558 | SEC |
| 2026-04-16 2026-04-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 881 | US$27.49 | US$24,218.69 | 400,777 | SEC |
| 2026-04-16 2026-04-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 288 | US$27.01 | US$7,778.88 | 401,658 | SEC |
| 2026-04-15 2026-04-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 2,044 | US$26.84 | US$54,860.96 | 401,946 | SEC |
| 2026-03-30 2026-04-01 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 2,968 | US$98.13 | US$291,249.84 | 58,117 | SEC |
| 2026-03-30 2026-04-01 | NUVL Nuvalent, Inc. | Noci Darlene Officer · Chief Development Officer | 卖出（S） | 2,532 | US$97.43 | US$246,692.76 | 61,085 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| NOC | 100,554.1782 | 65 | 289,856.4954 | 34.69% | B, Q, N |
| NOCT | 32.0161 | 0 | 2,619.3038 | 1.22% | Q |